Cell Culture Technology– category –
-
WuXi’s Integrated CRDMO Model: Powering Global Biopharma Innovation and Its Evolving Impact
ChinaTalk USA Overview This article from ChinaTalk analyzes WuXi Group's dominant position within the biotechnology industry, particularly its comprehensive Contract Research, Development, and Manufacturing Organization (CRDMO) model. It... -
FUJIFILM Diosynth Biotechnologies Secures 10-Year Biologics Manufacturing Deal with Regeneron
PharmaSource USA Overview FUJIFILM Diosynth Biotechnologies has inked a significant 10-year manufacturing agreement with Regeneron for the large-scale production of its biologics. This long-term partnership fortifies Fujifilm's position ... -
WuXi Biologics Hosts Third CRDMO Day in Tokyo, Accelerating Japanese Biopharma Innovation
PR Newswire Japan Overview WuXi Biologics successfully hosted its third CRDMO Day in Tokyo, gathering key leaders and experts from Japan's biopharmaceutical sector to discuss market trends and best practices in biologics innovation. The ... -
Lonza Completes Pure-Play CDMO Transition, Reports Strong Q1 2026 Driven by Robust Demand
TipRanks.com USA Overview Lonza announced strong Q1 2026 results, propelled by robust demand for its CDMO services, and completed the divestment of its Capsules & Health Ingredients division. This strategic move cements Lonza's posit... -
Sartorius Reports Strong Q1 2026, Bioprocess Solutions Driving 7.5% Revenue Growth
Alpha Spread Germany Overview Sartorius announced robust financial results for Q1 2026, propelled by a 7.5% revenue growth in its Bioprocess Solutions division on a constant currency basis. The company reaffirmed its full-year guidance, ... -
Sartorius Unveils Upgraded BIOSTAT STR Single-Use Bioreactor Family, Enhancing Biologics Scalability
Pharmaceutical Technology USA Overview Sartorius Stedim Biotech has released an enhanced BIOSTAT STR single-use stirred-tank bioreactor family, featuring upgraded hardware, software, and new Flexsafe STR bags. This scalable system suppor... -
Eppendorf Launches BioFlo 120 Bioprocess Control Station for Versatile Cell and Microbial Culture
BioProcess International USA Overview Eppendorf has introduced the BioFlo 120, a compact and highly versatile bioprocess control station engineered for both microbial and cell culture applications. This system provides precise control ov... -
Cell Culture Technology Weekly Report May 18, 2026
📄 Weekly Report May 18, 2026 (PDF) — Download Weekly Report May 18, 2026 (PDF) — DownloadDownload 🎙 Podcast May 17, 2026 (MP3) — Play & Download CellCultureTechnologyEnglishPodcast_20260517_sample.mp3Download -
Lonza Reports Strong Q1 2026 Performance, Driven by Robust CDMO Growth and Strategic Transformation into Pure-Play Biopharma Partner
Lonza Switzerland Overview Lonza delivered strong Q1 2026 performance across its Contract Development and Manufacturing Organization (CDMO) business, aligning with full-year expectations despite macroeconomic challenges. The company secu... -
Advanced 3D Bioprinting Techniques Drive Progress in Organoid and Tissue Development for Regenerative Medicine and Drug Discovery
News-Medical.Net UK Overview This technical article highlights advancements in 3D bioprinting for creating sophisticated organoid and tissue models, emphasizing their potential for cell therapy, personalized diagnostics, and drug discove...
